Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Truscreen Group's gross profit for the
six
months ended in Mar. 2026 was A$0.10 Mil. Truscreen Group's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.02 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Truscreen Group's gross profit for the
six
months ended in Mar. 2026 was A$0.10 Mil. Truscreen Group's Revenue for the
six
months ended in Mar. 2026 was A$1.36 Mil. Therefore, Truscreen Group's Gross Margin % for the quarter that ended in Mar. 2026 was 7.46%.
Truscreen Group had a gross margin of 7.46% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
During the past 13 years, the highestGross Margin % of Truscreen Group was 40.06%. The lowest was -0.50%. And the median was 30.63%.
Warning Sign:
Truscreen Group Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.5%.
Truscreen Group (ASX:TRU) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Truscreen Group had a gross margin of 7.46% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Truscreen Group Gross Profit Related Terms
Truscreen Group Gross Profit Historical Data
* Premium members only.
The historical data trend for Truscreen Group's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Truscreen Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Truscreen Group Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's Gross Profit distribution charts can be found below:
* The bar in red indicates where Truscreen Group's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.02 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Truscreen Group (ASX:TRU) has a Gross Profit of A$0.02 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Truscreen Group and its competitors.
Is Truscreen Group's Gross Profit too high?
Truscreen Group's current Gross Profit is A$0.02 Mil.
How does Truscreen Group's Gross Profit compare to ABT and SYK?
Truscreen Group's Gross Profit of A$0.02 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Truscreen Group and its competitors. Truscreen Group's current Gross Profit is A$0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Fairly Valued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 10% above its estimated fair value. The current Gross Profit is A$0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current Gross Profit is A$0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Truscreen Group Ltd is a New Zealand-based medical device company that develops, manufactures, and sells cervical cancer screening technology. Its principal product, the TruScreen device, uses optical and electrical measurements of cervical tissue to detect precancerous and cancerous changes in real time, offering an alternative to conventional cytology-based screening. The company also supplies associated consumables and HPV test kits used alongside its screening platform. TruScreen operates through a single business segment and sells primarily to healthcare providers, clinics, and distributors rather than directly to consumers. Its markets span China, Mexico, Vietnam, Indonesia, India, Central Asia, Zimbabwe, and the Middle East and North Africa, with China historically accounting for the largest share of revenue. Revenue is generated mainly through device sales and recurring consumable purchases, supported by regulatory approvals and distribution partnerships in each market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRU has been successfully added to your 
